Respiratory virus multiplex formulations desiccated on Copan’s FLOQSwab© for use as cross-platform compatible EQA samples and laboratory Quality Control

By Microbix Admin | November 10, 2022

Emerging requirements for infectious disease IVD quality control material

By Microbix Admin | November 10, 2022

Cross-Platform High-Risk (hr) Low Occurrence HPV NAAT Positive Samples of Use in Nucleic Acid Detection Testing as Prospective External Quality Assessment Samples and User Defined Quality Controls

By Microbix Admin | November 10, 2022

Novel Cross-Platform High-Risk (hr) HPV NAAT Positive Controls for Use in L1 and E6/E7 Targeted Nucleic ACID (DNA and RNA) Detection Methods

By Microbix Admin | November 8, 2022

Performance of full and extended genotyping assays using a new high-risk HPV multiplex panel

By Microbix Admin | November 7, 2022

Novel Mycoplasma genitalium (Mgen) and AMR Mgen A2059G Materials for use in a Cross-Platform NAAT Quality Control

By Microbix Admin | November 6, 2022

Simulated swab specimens for whole workflow quality control of SARS-CoV-2 molecular diagnostic testing

By Microbix Admin | November 5, 2022

Advanced SARS-CoV-2 Variants of Concern (VOC) whole-genome materials for use as verification, external quality assessment (EQA) and prospective quality control samples

By Microbix Admin | November 4, 2022

Advanced SARS-CoV-2 nucleocapsid protein swab-based formulation for use as a cross-platform EQA sample and as a prospective Quality Control

By Microbix Admin | November 3, 2022

Novel neutralizing anti-S1 SARS-CoV-2 human monoclonal antibody formulation for use as a cross-platform EQA sample and prospective quality controls

By Microbix Admin | November 2, 2022

Novel SARS-CoV-2 Full-Genome Material for Use in a Swab-Based Formulation as a Multi-Platform NAAT Quality Control

By Microbix Admin | November 1, 2022